📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cabrellis

1.1 - Company Overview

Cabrellis Logo

Cabrellis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical cancer therapy development, planning three small cell lung cancer clinical trials in 2006, including a study assessing the safety and efficacy of Calsed(TM) in reference to topotecan for second-line treatment.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cabrellis

Coordination Pharma Logo

Coordination Pharma

HQ: United States Website
  • Description: Provider of nanoparticle-based anticancer therapies, including CPI-100, which delivers immunostimulatory chemotherapeutic combinations directly to tumors. Offers the NCP platform using nanoscale coordination polymers to develop products targeting solid tumors, and seeks partnership opportunities to enhance current cancer immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coordination Pharma company profile →
IDEC Pharmaceuticals Logo

IDEC Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapy development targeting neurodegenerative, hematologic, and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IDEC Pharmaceuticals company profile →
Precision Biologics Logo

Precision Biologics

HQ: United States Website
  • Description: Provider of clinical-stage therapeutic and diagnostic products for the early detection and treatment of cancer, including monoclonal antibody drug candidates NEO-201 and Ensituximab (NEO-102), companion diagnostics (IHC and serum ELISA) to predict and monitor patient response, and clinical trials evaluating the efficacy of their therapeutic antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precision Biologics company profile →
Oncternal Therapeutics Logo

Oncternal Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage oncology treatments, developing a pipeline including ONCT-808, a ROR1-targeting autologous CAR T in Phase 1/2 for relapsed or refractory aggressive B-cell lymphoma; ONCT-534, a dual-action androgen receptor inhibitor for metastatic castration-resistant prostate cancer; and zilovertamab, a ROR1-targeting monoclonal antibody evaluated with other treatments for various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncternal Therapeutics company profile →
Living Pharma Logo

Living Pharma

HQ: United States Website
  • Description: Provider of Personalized CAR T Cell Therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Living Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cabrellis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cabrellis

2.2 - Growth funds investing in similar companies to Cabrellis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cabrellis

4.2 - Public trading comparable groups for Cabrellis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cabrellis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cabrellis

What does Cabrellis do?

Cabrellis is a provider of specialty pharmaceutical cancer therapy development, planning three small cell lung cancer clinical trials in 2006, including a study assessing the safety and efficacy of Calsed(TM) in reference to topotecan for second-line treatment.

Who are Cabrellis's competitors?

Cabrellis's competitors and similar companies include Coordination Pharma, IDEC Pharmaceuticals, Precision Biologics, Oncternal Therapeutics, and Living Pharma.

Where is Cabrellis headquartered?

Cabrellis is headquartered in United States.

How many employees does Cabrellis have?

Cabrellis has 1,000 employees 🔒.

When was Cabrellis founded?

Cabrellis was founded in 2010 🔒.

What sector and industry vertical is Cabrellis in?

Cabrellis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cabrellis

Who are the top strategic acquirers in Cabrellis's sector and industry

Top strategic M&A buyers and acquirers in Cabrellis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cabrellis?

Top strategic M&A buyers groups and sectors for Cabrellis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cabrellis's sector and industry vertical

Which are the top PE firms investing in Cabrellis's sector and industry vertical?

Top PE firms investing in Cabrellis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cabrellis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cabrellis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cabrellis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cabrellis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cabrellis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cabrellis?

The key public trading comparables and valuation benchmarks for Cabrellis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cabrellis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cabrellis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cabrellis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cabrellis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cabrellis's' sector and industry vertical?

Access recent funding rounds and capital raises in Cabrellis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cabrellis

Launch login modal Launch register modal